There is no experience with overdosage in clinical trials NP28761, NP28673 and BO28984. Patients who experience overdose should be closely supervised and supportive care instituted. There is no specific antidote for overdose with Alecensa.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
